cci 103f has been researched along with Neoplasms in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 6 (66.67) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Begg, AC; Bussink, J; Kaanders, JH; Ljungkvist, AS; Raleigh, JA; Rijken, PF; van der Kogel, AJ | 1 |
Chou, SC; Ji, X; Kleiter, MM; Lee, DY; Malarkey, DE; Raleigh, JA; Thrall, DE | 1 |
Cline, JM; Raleigh, JA; Rosner, GL; Thrall, DE | 2 |
Cline, JM; La Dine, JK; Raleigh, JA; Thrall, DE | 1 |
Azuma, C; McEntee, MC; Raleigh, JA; Rosner, GL; Thrall, DE | 1 |
Cline, JM; LaDine, JK; Raleigh, JA; Rathman, M; Thrall, DE; Zeman, EM | 1 |
Cline, JM; Franko, AJ; Page, RL; Raleigh, JA; Thrall, DE | 1 |
Best, MW; Franko, AJ; Koch, CJ; Miller, GG; Raleigh, JA | 1 |
9 other study(ies) available for cci 103f and Neoplasms
Article | Year |
---|---|
Hypoxic cell turnover in different solid tumor lines.
Topics: Animals; Benzimidazoles; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Coloring Agents; Half-Life; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Nitroimidazoles; Time Factors | 2005 |
A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker.
Topics: Administration, Oral; Animals; Area Under Curve; Cell Hypoxia; Cell Line; Cricetinae; Cricetulus; Dog Diseases; Dogs; Feasibility Studies; Hydrogen-Ion Concentration; Injections, Intravenous; Neoplasms; Nitroimidazoles | 2006 |
Distribution of the hypoxia marker CCI-103F in canine tumors.
Topics: Animals; Cell Hypoxia; Dog Diseases; Dogs; Female; Male; Neoplasms; Nitroimidazoles | 1994 |
An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours.
Topics: Animals; Biomarkers, Tumor; Calibration; Dogs; Enzyme-Linked Immunosorbent Assay; Hypoxia; Neoplasms; Nitroimidazoles; Tissue Distribution; Tritium | 1994 |
Quantification of CCI-103F labeling heterogeneity in canine solid tumors.
Topics: Analysis of Variance; Animals; Biomarkers; Cell Hypoxia; Dog Diseases; Dogs; Neoplasms; Nitroimidazoles; Oxygen; Reproducibility of Results | 1997 |
Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning.
Topics: Animals; Biopsy; Cell Hypoxia; Dog Diseases; Dogs; Neoplasms; Nitroimidazoles | 1997 |
Development of an ELISA for the detection of 2-nitroimidazole hypoxia markers bound to tumor tissue.
Topics: Animals; Cell Hypoxia; Dogs; Enzyme-Linked Immunosorbent Assay; Liposarcoma; Neoplasms; Nitroimidazoles; Sarcoma, Synovial | 1992 |
Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours.
Topics: Animals; Cell Hypoxia; Dog Diseases; Dogs; Immunohistochemistry; Neoplasms; Nitroimidazoles; Staining and Labeling | 1990 |
Quantitation of hypoxia in multicellular spheroids by video image analysis.
Topics: Autoradiography; Cell Aggregation; Cell Line; Fluorescence; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Neoplasms; Nitroimidazoles; Oxygen | 1989 |